Endothelin-1 for Early Risk Detection in Sustainable Health Strategies
Main Article Content
Abstract
Purpose: This study examines the role of endothelin-1 (ET-1) as a biomarker for the early identification of endothelial dysfunction and its contribution to aligning national health security with the Sustainable Development Goals (SDGs).
Design/methodology/approach: A quantitative approach is employed, using statistical analysis to explore the relationship between ET-1 and key cardiovascular indicators. Data are evaluated to determine the biomarker's potential in supporting preventive healthcare strategies.
Findings: The results indicate that ET-1 facilitates early detection of endothelial dysfunction, which precedes hypertension and cardiovascular disease. The use of ET-1 as a predictive indicator enables healthcare systems to shift from curative to preventive strategies, contributing to reduced disease burden and supporting SDG targets related to health financing and sustainability.
Practical implications: The findings provide a basis for health policymakers and practitioners to integrate ET-1 screening into national health programmes, particularly in resource allocation and early risk detection.
Originality/value: This study offers novel insights into the integrative function of ET-1, highlighting its strategic relevance in preventive health and sustainable development frameworks. It bridges clinical research with policy application in the context of national health resilience.
Article Details

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Banecki, K. M. R. M., & Dora, K. A. (2023). Endothelin-1 in Health and Disease